Literature DB >> 31077739

Predicting the non-survival outcome of large hemispheric infarction patients via quantitative electroencephalography: Superiority to visual electroencephalography and the Glasgow Coma Scale.

Mengdi Jiang1, Yingying Su2, Gang Liu1, Weibi Chen1, Daiquan Gao1.   

Abstract

BACKGROUND: Quantitative electroencephalography (QEEG) data are useful to predict outcomes of cerebral infarction patients. This study was performed to establish the value of QEEG in the prediction of outcomes in patients with large hemispheric infarction (LHI).
METHODS: A prognostic blinded cohort study was conducted on patients diagnosed with LHI in our neurocritical care unit. The electroencephalography (EEG) was recorded at the bedside within 3 days of LHI onset. Each EEG expert scored the raw EEG, and QEEG parameters including the absolute power, (delta + theta)/ (alpha + beta) ratio and brain symmetry index were obtained afterwards. Baseline data including Glasgow Coma Scale (GCS) was recorded at the meantime. Outcomes included survival or non-survival at the time of discharge and 6 months after the onset of LHI.
RESULTS: A total of 50 patients entered into the final analysis. There were no differences in baseline data or visual EEG grades between survival and non-survival groups. QEEG analysis showed that the absolute theta power of all of the electrodes and the contralateral electrodes was significantly higher in the non-survival group than in the survival group at discharge. Multivariable logistic regression analysis demonstrated that theta power of the contralateral electrodes was an independent predictor of death at discharge and at 6 months. Compared to the GCS and EEG grading, the QEEG index exhibited higher accuracy in predicting non-survival outcomes.
CONCLUSIONS: Among QEEG indices, theta power is valuable in predicting non-survival outcome in participants and is superior to visual EEG and GCS.
Copyright © 2019. Published by Elsevier B.V.

Entities:  

Keywords:  EEG grading; GCS; Large hemispheric infarction; Prognosis; Quantitative EEG

Mesh:

Year:  2019        PMID: 31077739     DOI: 10.1016/j.neulet.2019.05.007

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  6 in total

1.  Early Consciousness Disorder in Acute Large Hemispheric Infarction: An Analysis Based on Quantitative EEG and Brain Network Characteristics.

Authors:  Huijin Huang; Zikang Niu; Gang Liu; Mengdi Jiang; Qingxia Jia; Xiaoli Li; Yingying Su
Journal:  Neurocrit Care       Date:  2020-07-23       Impact factor: 3.210

2.  The Prognostic Utility of Electroencephalography in Stroke Recovery: A Systematic Review and Meta-Analysis.

Authors:  Amanda A Vatinno; Annie Simpson; Viswanathan Ramakrishnan; Heather S Bonilha; Leonardo Bonilha; Na Jin Seo
Journal:  Neurorehabil Neural Repair       Date:  2022-03-20       Impact factor: 3.919

3.  EEG spectral exponent as a synthetic index for the longitudinal assessment of stroke recovery.

Authors:  J Lanzone; M A Colombo; S Sarasso; F Zappasodi; M Rosanova; M Massimini; V Di Lazzaro; G Assenza
Journal:  Clin Neurophysiol       Date:  2022-03-08       Impact factor: 4.861

Review 4.  Surface electroencephalography (EEG) during the acute phase of stroke to assist with diagnosis and prediction of prognosis: a scoping review.

Authors:  Lou Sutcliffe; Hannah Lumley; Lisa Shaw; Richard Francis; Christopher I Price
Journal:  BMC Emerg Med       Date:  2022-02-28

5.  Quantitative EEG parameters can improve the predictive value of the non-traumatic neurological ICU patient prognosis through the machine learning method.

Authors:  Jia Tian; Yi Zhou; Hu Liu; Zhenzhen Qu; Limiao Zhang; Lidou Liu
Journal:  Front Neurol       Date:  2022-07-28       Impact factor: 4.086

6.  Multimodal Monitoring in Large Hemispheric Infarction: Quantitative Electroencephalography Combined With Transcranial Doppler for Prognosis Prediction.

Authors:  Yajie Qi; Yingqi Xing; Lijuan Wang; Jie Zhang; Yanting Cao; Li Liu; Ying Chen
Journal:  Front Neurol       Date:  2021-12-08       Impact factor: 4.003

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.